Navigation Links
TGen breast cancer research benefits from $3.5 million Komen award
Date:9/23/2011

andomized clinical trial will be planned.

"TGen scientists lead by Dr. John Carpten have been at the forefront of cancer health disparities research for more than a decade," said Dr. Trent, President and Research Director of TGen and VARI. "This study is at the vanguard of treatments that are aimed at the most deadly form of human breast cancer in a this highly vulnerable patient population."

Joining Drs. Trent and Wicha as the third principal investigator on the grant is Dr. Patricia LoRusso, D.O., Professor of Medicine at Karmanos. Dr. LoRusso is one of the world's leading physicians in the development of new drugs for cancer patients. Her major focus over nearly 20 years has been addressing the need for new cancer treatments for women with breast cancer, especially those of African American decent.

More than 209,000 Americans will be diagnosed with breast cancer this year and more than 40,000 will die from the disease.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Breast cancer treatment resistance linked to signaling pathway
2. The dietary supplement genistein can undermine breast cancer treatment
3. Breast cancer cells recycle to escape death by hormonal therapy
4. Second lumpectomy for breast cancer reduces survival rates
5. Study looks at psychological impact of gene test for breast cancer
6. SNM releases new fact sheet on breast cancer and molecular imaging
7. Study links nicotine with breast cancer growth and spread
8. UC Davis researchers discover a key to aggressive breast cancer
9. CTRC-AACR San Antonio Breast Cancer Symposium
10. Einstein researchers develop a new way to study how breast cancer spreads
11. Mayo researchers identify dangerous two-faced protein crucial to breast cancer spread and growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... The rise of the Tibetan plateau -- the largest ... important for both its profound effect on climate and ... in GSA Bulletin , Katharine Huntington and colleagues ... -- using modern and fossil snail shells to investigate ... Tibet. , Views range widely on the timing ...
(Date:8/28/2014)... This news release is available in German . ... fresh water fish, owes its name to a striking pattern ... cell types, black cells, reflective silvery cells, and yellow cells ... fish and arrange as a multilayered mosaic to compose the ... all three cell types have to interact to form proper ...
(Date:8/28/2014)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for the Genetics Society of America,s 27th ... October 3, 2014 in Pacific Grove, California. ... entry of students, post doctorates and scientists from ... science community and to encourage the participation of ...
Breaking Biology News(10 mins):Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3
... bumblebee species from an ecosystem and the impact is ... seeds, a new study finds. The study, to ... Academy of Sciences , focused on the interactions between ... results show how reduced competition among pollinators disrupts floral ...
... , July 26, 2013 /PRNewswire-iReach/ -- TestoMeds is ... discounts online for those seeking testosterone or progesterone ... deficiencies. (Photo: http://photos.prnewswire.com/prnh/20130726/MN54049 ) ... testosterone replacement creams – Androforte, Androfeme, and ...
... relevant information while ignoring distractions is a core brain ... "noise," we could not effectively interact with our environment. ... cellular mechanisms responsible for the effects of attention have ... in the journal Nature , researchers from Dartmouth,s ...
Cached Biology News:Bees 'betray' their flowers when pollinator species decline 2Bees 'betray' their flowers when pollinator species decline 3Bees 'betray' their flowers when pollinator species decline 4Androforte for Low T is Better Absorbed and More Economical than Androgel or Testim! 2Androforte for Low T is Better Absorbed and More Economical than Androgel or Testim! 3Androforte for Low T is Better Absorbed and More Economical than Androgel or Testim! 4
(Date:8/28/2014)... SunTrust Robinson Humphrey (STRH) today announced the ... research team in biotechnology and oilfield services.  ... demonstrates our commitment to providing our valued institutional ... decision making," said Biff Woodruff , Head ... significant investments in differentiated content at a time ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/27/2014)... August 27, 2014 Varian Medical Systems ... its current Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full time jobs ... , “Utah is home to hardworking people with immense ... credited with Varian’s success in the manufacturing of our ...
(Date:8/27/2014)... , Aug. 27, 2014   MSC , a ... safety, today announced the appointment of Mary Beth ... With 28 years of experience preparing companies for rapid ... as Executive Vice President of Corporate Development and Healthcare. ... improvement business , as well as corporate strategy and ...
Breaking Biology Technology:SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3MSC names Mary Beth Loesch President and CEO 2
... activity (regenerative potential) of stem cells and accelerates ... MaxCyte announces today the introduction of its ... Stem Cell Summit to be held in New ... is a validated, scalable technology for customizing the ...
... Feb. 17 Human Genome Sciences, Inc. (Nasdaq: ... GSK ) has initiated a Phase 3 clinical ... of Syncria (R) (albiglutide) in the long-term treatment ... HGS will receive a $9 million milestone payment in ...
... VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) announced ... (NDA) with the U.S. Food and Drug Administration (FDA) ... a single agent for remission induction treatment for patients ... novo poor-risk acute myeloid leukemia (AML). The ...
Cached Biology Technology:MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies 2MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM) 2Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM) 3Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM) 4